Professor of Medicine, University of Texas Medical Branch at Galveston
Infectious Disease
Dr. Philip Keiser, MD
|
|
Give Review
Philip Keiser is an expert in the field of Infectious Disease. He went to medical school at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care He has 18 awards "Teaching Award", "Houston's Best Doctors", "America's Top Doctors", "Marshall for UTMB Medical School Graduation", "Top Doctors:SE Texas", "Texas Super Doctors", "America's Best Doctors", "Distinguished Physician Award", "Outstanding Preceptor Award for Sustained Effort in Clinical Teaching", "Brady Allen-Crystal Hope Award for Contribution to the HIV Community", "Residents Award for Excellence in Teaching and Patient Care", "Alpha Omega Alpha Honor Medical Society", "James H. Birney/Smith-Kline-French Award", "Excellence in Chemistry", "Pi Mu Epsilon Mathematics Honor Society", "Analytical Chemistry Award", "Alpha Kappa Mu Honor Society" and "Chemical Rubber Company Award for Achievement in Freshman Chemistry". Philip Keiser is a published doctor and has 56 publications published. The lastest was: 'Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital.' Philip Keiser, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Factors associated with general self-efficacy and resilience among youth heads of households in Kenya.
- Mycobacterium tuberculosis-specific CD8(+)T cell recall in convalescing TB subjects with HIV co-infection.
- The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.
- The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
- Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplif...
- A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.
- Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational...
- Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
- Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is ass...
- Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
- Changes in thymic function with age and during the treatment of HIV infection.
- Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
- Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.
- Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
- A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection.
- Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital.
- Long-term impact of highly active antiretroviral therapy on HIV-related health care costs.
- Evidence for increased T cell turnover and decreased thymic output in HIV infection.
- Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis.
- An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.
- G-CSF association with prolonged survival in HIV-infected patients with disseminated Mycobacterium avium complex infection.
- Trizivir.
- Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
- An open-label pilot study of the efficacy and tolerability of once-daily didanosine versus twice-daily didanosine.
- Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
- Sexual Behavior Among Young Carers in the Context of a Kenyan Empowerment Program Combining Cash-Transfer, Psychosocial Support, and Entrepreneurship.
- Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
- Prednisone therapy is not associated with increased risk of herpetic infections in patients infected with human immunodeficiency virus.
- Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.
- Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
- Southwestern Internal Medicine Conference. Keeping travelers healthy.
- A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immuno...
- Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate.
- Osteonecrosis in HIV: a case-control study.
- Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians' beliefs, practices, and knowledge.
- Contemporary costs of HIV healthcare in the HAART era.
- Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus.
- Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients.
- Role of sequencing in therapy selection.
- Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
- Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
- Clinical significance of eosinophilia in HIV-infected individuals.
- Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
- Nontunneled central venous catheters in patients with AIDS are associated with a low infection rate.
- Efficacy of nelfinavir in patients switched from ritonavir/saquinavir combination antiretroviral therapy.
- Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
- Utility of bone marrow culture and biopsy in the diagnosis of disseminated infections in AIDS.
- Hypersensitivity of zidovudine: report of a case of anaphylaxis and review of the literature.
- A quality assessment tool for tuberculosis control activities in resource limited settings.
- Anti-CD4 antibodies generated in response to HIV-1 rgp160 immunization of HIV-1-infected chimpanzees.
- Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.
- Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
- Sporotrichosis in human immunodeficiency virus-infected patients: report of a case.
- Anti-CD4 antibodies are associated with HIV-1 seroconversion and may be detectable before anti-HIV-1 antibodies. The Multicenter AIDS Cohort Study.
- Exploring Pathways Between HIV+ Status and Excellent Overall Health Among Kenyan Women: Family Functioning, Meaningfulness of Life, Seroconcordance, Social Support and...
Schools
University of Maryland At Baltimore Professional Schools
Francis Scott Key Med Center
University MD
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Teaching Award
- Houston's Best Doctors
- America's Top Doctors
- Marshall for UTMB Medical School Graduation
- Top Doctors:SE Texas
- Texas Super Doctors
- America's Best Doctors
- Distinguished Physician Award
- Outstanding Preceptor Award for Sustained Effort in Clinical Teaching
- Brady Allen-Crystal Hope Award for Contribution to the HIV Community
- Residents Award for Excellence in Teaching and Patient Care
- Alpha Omega Alpha Honor Medical Society
- James H. Birney/Smith-Kline-French Award
- Excellence in Chemistry
- Pi Mu Epsilon Mathematics Honor Society
- Analytical Chemistry Award
- Alpha Kappa Mu Honor Society
- Chemical Rubber Company Award for Achievement in Freshman Chemistry
Education
-
University of Maryland -
Johns Hopkins Bayview Medical Center -
University of Maryland School of Medicine
Drug Facts
| NPI NUMBER | 1790748424 | |
| NPPES Provider LastName | KEISER | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1767.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 377.0 | |
| Percent Opioid Claims | 21.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790748424 |
| Last Name Of The Provider | KEISER |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Dr. Juan C. Sarria, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clovus G. Mayhall, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Alfred Lea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Melby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin Katz, OD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis M. Walling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur C. White Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alice A. O'Donell, MD
This Doctor is OpenDoctor Recommended.
|